Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1989 2
1990 1
1991 1
1992 3
1993 1
1997 2
1998 3
1999 3
2000 3
2001 4
2002 5
2003 3
2004 3
2005 8
2006 2
2007 4
2008 8
2009 9
2010 12
2011 17
2012 17
2013 20
2014 17
2015 22
2016 31
2017 19
2018 30
2019 37
2020 31
2021 40
2022 38
2023 32
2024 26
2025 7

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

370 results

Results by year

Filters applied: . Clear all
Page 1
Towards a Consensus on the Management of Metastatic Renal Cell Carcinoma: Insights from a European Delphi Study.
Albiges L, Gross-Goupil M, Barthélémy P, Bamias A, Bedke J, Bex A, Fontes-Sousa M, Grünwald V, Melichar B, Pickering L, Porta C, Procopio G, Rottey S, Schmidinger M, Suárez C, Velasco G, Escudier B. Albiges L, et al. Among authors: bex a. Eur Urol Oncol. 2025 Feb 8:S2588-9311(25)00028-8. doi: 10.1016/j.euo.2025.01.007. Online ahead of print. Eur Urol Oncol. 2025. PMID: 39924391
Updated European Association of Urology Guidelines on the Use of Adjuvant Immune Checkpoint Inhibitors and Subsequent Therapy for Renal Cell Carcinoma.
Bedke J, Ghanem YA, Albiges L, Bonn S, Campi R, Capitanio U, Dabestani S, Hora M, Klatte T, Kuusk T, Lund L, Marconi L, Palumbo C, Pignot G, Powles T, Tran M, Volpe A, Bex A. Bedke J, et al. Among authors: bex a. Eur Urol. 2025 Feb 3:S0302-2838(25)00026-0. doi: 10.1016/j.eururo.2025.01.014. Online ahead of print. Eur Urol. 2025. PMID: 39904712
A Call for a Neoadjuvant Kidney Cancer Consortium: Lessons Learned from Other Cancer Types.
Bex A, Jewett M, Lewis B, Abel EJ, Albiges L, Berg SA, Bratslavsky G, Braun D, Brugarolas J, Choueiri TK, Finelli A, George D, Haas NB, Hakimi AA, Hammers H, Hirsch M, Jonasch E, Kapur P, Linehan WM, Master V, McGregor B, McKay RR, Mehra R, Pal S, Poteat S, Powles TB, Rossi SH, Shapiro DD, Signoretti S, Singer EA, Stravin C, Tannir N, Vaishampayan U, Xu W, Stewart GD. Bex A, et al. Eur Urol. 2025 Jan 23:S0302-2838(25)00018-1. doi: 10.1016/j.eururo.2025.01.007. Online ahead of print. Eur Urol. 2025. PMID: 39855942
Is Frequent Imaging Necessary? Impact of Computed Tomography During Follow-up After Surgical Treatment for Nonmetastatic Renal Cell Carcinoma: A Systematic Review.
van den Brink L, Reijerink MAA, Henderickx MMEL, Bex A, Jamaludin FS, Beerlage HP, van Delden OM, van Moorselaar RJA, Stoker J, Bipat S, Zondervan PJ. van den Brink L, et al. Among authors: bex a. Eur Urol Oncol. 2024 Dec 10:S2588-9311(24)00276-1. doi: 10.1016/j.euo.2024.11.014. Online ahead of print. Eur Urol Oncol. 2024. PMID: 39665918 Free article. Review.
Adapting the design of the ongoing RAMPART trial in response to external evidence: An example for trials which take many years to run and report.
Meade A, Frangou E, Choodari-Oskooei B, Larkin J, Powles T, Stewart GD, Albiges L, Bex A, Choueiri TK, Davis ID, Eisen T, Fielding A, Gedye C, Harrison DJ, Kaplan R, Mulhere S, Nathan P, Patel G, Patel J, Plant H, Ritchie A, Rush H, Shakeshaft C, Stockler MR, Suarez C, Thompson J, Thorogood N, Venugopal B, Parmar MKB. Meade A, et al. Among authors: bex a. Contemp Clin Trials Commun. 2024 Oct 18;42:101381. doi: 10.1016/j.conctc.2024.101381. eCollection 2024 Dec. Contemp Clin Trials Commun. 2024. PMID: 39555240 Free PMC article.
First and Second-line Treatments in Metastatic Renal Cell Carcinoma.
Barragan-Carrillo R, Saad E, Saliby RM, Sun M, Albiges L, Bex A, Heng D, Mejean A, Motzer RJ, Plimack ER, Powles T, Rini BI, Zhang T, Choueiri TK. Barragan-Carrillo R, et al. Among authors: bex a. Eur Urol. 2025 Feb;87(2):143-154. doi: 10.1016/j.eururo.2024.10.019. Epub 2024 Nov 6. Eur Urol. 2025. PMID: 39505582 Review.
PrimerX: A Bayesian Multistage Cohort Embedded Randomised Trial to Evaluate the Role of Deferred Local Therapy of the Primary Tumour in Combination with Immune Checkpoint Inhibitor-based First-line Therapy in Metastatic Renal Cell Carcinoma Patients.
Figaroa O, Zondervan P, Kessels R, Berkhof J, Aarts M, Hamberg P, Los M, Piersma D, Rikhof B, Suelmann B, Tascilar M, van der Veldt A, Verhagen P, Westgeest H, Yildirim H, Bex A, Bins A. Figaroa O, et al. Among authors: bex a. Eur Urol Open Sci. 2024 Oct 14;70:28-35. doi: 10.1016/j.euros.2024.09.002. eCollection 2024 Dec. Eur Urol Open Sci. 2024. PMID: 39483517 Free PMC article.
Neoadjuvant and Adjuvant Immune-based Approach for Renal Cell Carcinoma: Pros, Cons, and Future Directions.
Marandino L, Campi R, Amparore D, Tippu Z, Albiges L, Capitanio U, Giles RH, Gillessen S, Kutikov A, Larkin J, Motzer RJ, Pierorazio PM, Powles T, Roupret M, Stewart GD, Turajlic S, Bex A. Marandino L, et al. Among authors: bex a. Eur Urol Oncol. 2024 Sep 25:S2588-9311(24)00211-6. doi: 10.1016/j.euo.2024.09.002. Online ahead of print. Eur Urol Oncol. 2024. PMID: 39327187 Free article. Review.
370 results